homoorientin has been researched along with Insulin Resistance in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dludla, PV; Joubert, E; Kappo, AP; Louw, J; Mazibuko-Mbeje, SE; Muller, CJF; Nkambule, BB; Tiano, L; Ziqubu, K | 1 |
| Alonso-Castro, AJ; Gómez-Espinoza, G; Salazar-Olivo, LA; Zapata-Bustos, R | 1 |
1 review(s) available for homoorientin and Insulin Resistance
| Article | Year |
|---|---|
Isoorientin: A dietary flavone with the potential to ameliorate diverse metabolic complications.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Diabetes Mellitus; Diet; Humans; Insulin Resistance; Luteolin; Metabolic Diseases; Oxidative Stress | 2020 |
1 other study(ies) available for homoorientin and Insulin Resistance
| Article | Year |
|---|---|
Isoorientin reverts TNF-α-induced insulin resistance in adipocytes activating the insulin signaling pathway.
Topics: 4-Chloro-7-nitrobenzofurazan; Adipocytes; Animals; Cell Line; Deoxyglucose; Glucose Transporter Type 4; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Luteolin; Mice; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, Insulin; Signal Transduction; Tumor Necrosis Factor-alpha | 2012 |